Table 4.
Summary of PubMed-indexed English publications on CL.
| Year | Authors | BC lesions (N) | Imaging modality used for CL | Successful BC tumor identification (%) | Time of localization (days) | One-stage complete resection (%) | Tumor size (in mm) | Breast surgical specimen volume (median, cm3) |
|---|---|---|---|---|---|---|---|---|
| 1983 | Svane [10] | 56 | Stereotaxic | 96.4 | 0–57 | 92.8 | 5–21 | — |
| 1991 | Langlois and Carter [14] | 56 | Stereotaxic | — | 0–42 | — | 1–45 | — |
| 1995 | Canavese et al. [15] | 158 | Ultrasound (25.3%) Stereotaxic (74.7) |
— | — | — | 3–38 | — |
| 2001 | Mullen et al. [13] | 118 | Stereotaxic | 98.3 | 0–83 | 62.7 | — | 216.5 |
| 2002 | Moss et al. [16] | 138 | Ultrasound (3.6%) Stereotaxic (96.4%) |
100∗ | 0 | 76.1 | — | 125.6 |
| 2003 | Rose et al. [17] | 219 | Ultrasound (48.4%) Stereotaxic (51.6%) |
99 | — | 75.3 | — | — |
| 2007 | Ko et al. [18] | 109 | Ultrasound | 99.1 | 0–57 | — | 4–32 | — |
| 2015 | Jiang et al. [19] | 16 | Ultrasound | 100 | 0–3 | 100 | — | — |
| 2021 | Zhou et al. [20] | 109 | Ultrasound | — | 0–5 | 100∗∗ | — | 2.51 |
| 2022 | This study | 564 | Ultrasound (98.5%) Stereotaxic (1.5%) |
98.9 | 0–60 | 93.4 | 1.5–40 | 44 |
∗ , combined WGL and CL; ∗∗, all of the breast lesions were benign.